Literature DB >> 11813864

Immunohistochemical study of human pterygium.

M T Perra1, C Maxia, I Zucca, F Piras, P Sirigu.   

Abstract

The purpose of this study has been to evaluate the immunohistochemical characteristics of human pterygial tissues in order to ascertain the possible contribution of an immunological mechanism in the pathogenesis of pterygium and to investigate the presence in the pterygial tissues of some melanoma-associated antigens, in order to evaluate if there may be a small possibility of correlation of the two diseases. Human biopsy specimens of pterygium were obtained by surgery for pterygium excision. Tissue segments were fixed and processed for paraffin embedding. Microtome sections were treated for the immunohistochemical demonstration of IgA, IgM, IgG, CD3, CD20, CD68, HLA-DR, Protein S100, HMB45, and Melan A using the avidin-biotin peroxidase method or the streptavidin biotin-alkaline phosphatase method. The findings suggest that all the effector components of the mucosal immune system are present in the human pterygium and, among the most sensitive markers for melanoma, only S100 shows immunoreactivity. An immunopathogenetic mechanism seems to be responsible for the pathogenesis of pterygium, perhaps being caused by pre-existing conjunctivitis or microtrauma in combination with the patient's predisposition. No correlation between pterygium and melanoma was found.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11813864     DOI: 10.14670/HH-17.139

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  11 in total

1.  Detection of human papillomavirus DNA in pterygia from different geographical regions.

Authors:  F Piras; P S Moore; J Ugalde; M T Perra; A Scarpa; P Sirigu
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

2.  Ophthalmic pterygium: a stem cell disorder with premalignant features.

Authors:  Jeanie Chui; Minas T Coroneo; Lien T Tat; Roger Crouch; Denis Wakefield; Nick Di Girolamo
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Cyclooxygenase-2-expressing macrophages in human pterygium co-express vascular endothelial growth factor.

Authors:  Choul Yong Park; Jong Sun Choi; Sung Jun Lee; Sang Won Hwang; Eo-Jin Kim; Roy S Chuck
Journal:  Mol Vis       Date:  2011-12-29       Impact factor: 2.367

4.  Relationship between expression of cyclooxygenase 2 and neovascularization in human pterygia.

Authors:  Zhengxuan Jiang; Liming Tao; Dongwei Liu; Chang Peng
Journal:  Oncotarget       Date:  2017-11-09

5.  Vitamin D and vitamin D receptor in patients with ophthalmic pterygium.

Authors:  Cristina Maxia; Daniela Murtas; Michela Corrias; Ignazio Zucca; Luigi Minerba; Franca Piras; Cristiana Marinelli; Maria Teresa Perra
Journal:  Eur J Histochem       Date:  2017-10-30       Impact factor: 3.188

6.  Immunophenotypic characterization of telocyte-like cells in pterygium.

Authors:  Cristina Maxia; Daniela Murtas; Michela Isola; Roberto Tamma; Ignazio Zucca; Franca Piras; Domenico Ribatti; Andrea Diana; Maria Teresa Perra
Journal:  Mol Vis       Date:  2018-12-29       Impact factor: 2.367

7.  DNA damage in human pterygium: one-shot multiple targets.

Authors:  Anca Maria Cimpean; Mihai Poenaru Sava; Marius Raica
Journal:  Mol Vis       Date:  2013-02-07       Impact factor: 2.367

8.  Intraoperative ethanol treatment as an adjuvant therapy of pterygium excision.

Authors:  Ko-Hua Chen; Wen-Ming Hsu
Journal:  Int J Biomed Sci       Date:  2006-12

9.  Relationship between the expression of cyclooxygenase-2 and survivin in primary pterygium.

Authors:  Cristina Maxia; Maria Teresa Perra; Paolo Demurtas; Luigi Minerba; Daniela Murtas; Franca Piras; Renè Cabrera; Domenico Ribatti; Paola Sirigu
Journal:  Mol Vis       Date:  2009-02-27       Impact factor: 2.367

10.  Expression of survivin protein in pterygium and relationship with oxidative DNA damage.

Authors:  C Maxia; M T Perra; P Demurtas; L Minerba; D Murtas; F Piras; A Corbu; D C Gotuzzo; R G Cabrera; D Ribatti; P Sirigu
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.